Embedding equity in international research collaboration

International collaboration is central to the Wellcome Sanger Institute’s mission to ‘apply and explore genomic technologies at scale to advance understanding of biology and improve health’. A significant portion of Sanger's research is performed in collaboration with partners based in low- and middle-income countries (LMICs), and it is a priority for the Institute to ensure that principles of mutual benefit and equity are embedded in these partnerships as it works towards a culture of research excellence.

This report seeks to support Sanger research teams to collaborate equitably with partners through two sections:

1. A working definition of an equitable collaboration
2. Guidelines for Sanger research teams to collaborate equitably with partners based in LMICs

Short summary guidelines are also provided.